Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03277547 · ClinicalTrials.gov registry record

Kidney Function in Sickle Cell Anemia

A clinical trial of Sickle Cell Disease and Kidney Failure, Chronic, sponsored by Kenneth Ataga MD.

Active
Registry status
300
Enrollment target
3
Study locations

NCT03277547 is a study of Sickle Cell Disease and Kidney Failure, Chronic that is active but no longer recruiting, run by Kenneth Ataga MD. The registered enrollment target is 300 participants, roughly in line with the 291-participant average among 213 other Sickle Cell Disease trials with a reported enrollment target. The trial reports 3 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03277547, a study of Sickle Cell Disease and Kidney Failure, Chronic, is active but no longer recruiting, sponsored by Kenneth Ataga MD.

ACTIVE NOT RECRUITING
Registry status
300 participants
Enrollment target
3
Study locations

Study Summary

This is a prospective clinical cohort study that involves a baseline study visit followed by up to 3 annual follow-up study visits for a total follow-up of 36-48 months to evaluate the age- and sex-adjusted rate of change in kidney function, and to identify biomarkers of endothelial function, metabolomic profiles and clinical characteristics for the worsening of kidney function and for a rapid decline in kidney function. "Funding Source - FDA OOPD"

Conditions Studied

Sickle Cell Disease Kidney Failure, Chronic

Study Locations (3)

North Carolina

  • University of North Carolina-Chapel Hill - Chapel Hill

Ohio

  • Ohio State Adult Sickle Cell Program - Columbus

Tennessee

  • UTHSC Center for Sickle Cell Disease - Memphis

Trial Details

FieldValue
Enrollment Target 300 participants
Start Date 2017-11-17
Est. Completion 2025-12-01

Sponsor

Kenneth Ataga MD

1 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03277547

The ClinicalTrials.gov registry entry for NCT03277547 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 291-participant average among 213 other Sickle Cell Disease trials with a reported enrollment target. The listed sponsor is Kenneth Ataga MD, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Sickle Cell Disease appearing as the primary indexed condition, and to 0 interventions.

NCT03277547 reports 3 study locations spanning 3 distinct geographic areas - top geographies include North Carolina, Ohio, Tennessee.

Frequently Asked Questions

What is clinical trial NCT03277547 about?

NCT03277547 is a clinical study titled "Kidney Function in Sickle Cell Anemia". This is a prospective clinical cohort study that involves a baseline study visit followed by up to 3 annual follow-up study visits for a total follow-up of 36-48 months to evaluate the age- and sex-adjusted rate of change in kidney function, and to identify biomarkers of endothelial function, metabo...

What is the current status of trial NCT03277547?

This trial is currently active not recruiting. The enrollment target is 300 participants. The study started on 2017-11-17. Estimated completion is 2025-12-01.

What conditions does trial NCT03277547 study?

This clinical trial studies the following conditions: Sickle Cell Disease, Kidney Failure, Chronic.

Who is sponsoring clinical trial NCT03277547?

This trial is sponsored by Kenneth Ataga MD, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03277547 being conducted?

This trial has 3 study locations across North Carolina, Ohio, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Sickle Cell Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Sickle Cell Disease

All registered trials for this condition

Kidney Failure, Chronic

All registered trials for this condition

North Carolina

All trials with a study site in North Carolina

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.